Castle Biosciences Unveils Strategy in Management Presentations
PremiumCompany AnnouncementsCastle Biosciences Unveils Strategy in Management Presentations
2M ago
Castle Biosciences raises FY24 revenue view to $275M-$300M, consensus $260.39M
Premium
The Fly
Castle Biosciences raises FY24 revenue view to $275M-$300M, consensus $260.39M
2M ago
Castle Biosciences reports Q2 EPS 31c vs (70c) last year
Premium
The Fly
Castle Biosciences reports Q2 EPS 31c vs (70c) last year
2M ago
Castle Biosciences slides after MolDX determination on carcinoma test
PremiumThe FlyCastle Biosciences slides after MolDX determination on carcinoma test
3M ago
Castle Biosciences announces latest AGA guideline on NDBE
Premium
The Fly
Castle Biosciences announces latest AGA guideline on NDBE
3M ago
Castle Biosciences reports inducement grants under Nasdaq rule
Premium
The Fly
Castle Biosciences reports inducement grants under Nasdaq rule
3M ago
Castle Biosciences price target raised to $34 from $33 at Baird
PremiumThe FlyCastle Biosciences price target raised to $34 from $33 at Baird
5M ago
Castle Biosciences raises FY24 revenue vie to $255M-$265M from $235M-$240M
Premium
The Fly
Castle Biosciences raises FY24 revenue vie to $255M-$265M from $235M-$240M
5M ago
Castle Biosciences reports Q1 EPS (9c), consensus (33c)
Premium
The Fly
Castle Biosciences reports Q1 EPS (9c), consensus (33c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100